Tumor necrosis factor in myocardial hypertrophy and ischaemia--an anti-apoptotic perspective.
Sack
M N
MN
Hatter Institute for Cardiology Research, Cape Heart Centre, University of Cape Town Medical School, South Africa. sack@samiot.uct.ac.za
Smith
R M
RM
Opie
L H
LH
D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial; D020935:MAP Kinase Signaling System; D009200:Myocardial Contraction; D017202:Myocardial Ischemia / Q000378:metabolism* / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism*; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013314:Stress, Mechanical; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*
D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha